PRESS RELEASE published on 01/01/2023 at 00:30, 3 years 7 months ago Ivrnet Inc. Announces Amendment to Term Loan and Credit Facility
PRESS RELEASE published on 10/31/2022 at 18:23, 3 years 9 months ago Paulic Meunerie : annule et remplace : Rapport financier semestriel 2022
PRESS RELEASE published on 11/24/2020 at 14:30, 5 years 8 months ago PJSC Magnit notifies on the transactions by persons discharging managerial responsibilities and persons clearly associated with them (PDMR/PCA)
PRESS RELEASE published on 11/24/2020 at 13:00, 5 years 8 months ago Royal KPN N.V. Press Release: Members of Board of Management buy KPN shares
Published on 08/10/2026 at 08:00, 2 hours 6 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 2 hours 6 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 10 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 09:50, 16 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 1 hour 6 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 6 minutes ago Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 6 minutes ago Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
Published on 08/10/2026 at 09:22, 44 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 44 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 3 hours 6 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 3 hours 6 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité